Indeed, selective inhibition of GLUT1 in squamous cell lung cancer using WZB117, a small molecular GLUT1 inhibitor, reduced tumor growth of HCC1588 and HCC2814 cSCCs by 40% while adenocarcinoma H1299 tumor growth remained unaffected [212]. The gene discussed is SLC2A1; the disease is squamous cell lung carcinoma.